Search research articles
Contact Us
Filters
Showing results (221-230 of 285) with videos related to
Page
of 29
Sort By:
Pulmonary Pharmacology & Therapeutics
|
December 1, 2020
An expert panel delphi consensus statement on patient selection and management for transitioning between oral and inhaled treprostinil
Franck F Rahaghi, Roblee P Allen, Vijay P Balasubramanian, et al.
BMC Infectious Diseases
|
December 26, 2001
Absence of rapid selection for acyclovir or penciclovir resistance following suboptimal oral prodrug therapy of HSV-infected mice
R T Sarisky, H R Bartus, S A Dennis, et al.
Respiratory Medicine
|
March 19, 2023
Establishing a balloon pulmonary angioplasty program for chronic thromboembolic pulmonary hypertension: A United States single-center experience
Lauren N Carlozzi, Josh Lee, Lia M Barros, et al.
Annals of the American Thoracic Society
|
September 8, 2023
Regional Variation in Pulmonary Arterial Hypertension in the United States: The Pulmonary Hypertension Association Registry
Connor Fling, Teresa De Marco, Noah A Kime, et al.
Circulation. Heart Failure
|
October 22, 2024
Proteomic Signatures of Right Ventricular Outcomes in Pulmonary Arterial Hypertension
Hongyang Pi, Lu Xia, Olivier Boucherat, et al.
Antimicrobial Agents and Chemotherapy
|
May 11, 1992
Human immunodeficiency virus type 1 protease inhibitors irreversibly block infectivity of purified virions from chronically infected cells
D M Lambert, S R Petteway, C E McDanal, et al.
The American Journal of Cardiology
|
September 22, 2012
Von Willebrand factor and the right ventricle (the MESA-Right Ventricle Study)
Peter J Leary, R Graham Barr, David A Bluemke, et al.
Chest
|
January 6, 2025
Effect of Famotidine on Outcomes in Pulmonary Arterial Hypertension: A Randomized Controlled Trial
Peter J Leary, Samuel G Rayner, Kelley R H Branch, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
November 17, 2001
Biochemical characterization of a virus isolate, recovered from a patient with herpes keratitis, that was clinically resistant to acyclovir
R T Sarisky, R Cano, T T Nguyen, et al.
Annals of the American Thoracic Society
|
July 30, 2020
A Survey-based Estimate of COVID-19 Incidence and Outcomes among Patients with Pulmonary Arterial Hypertension or Chronic Thromboembolic Pulmonary Hypertension and Impact on the Process of Care
Joshua D Lee, Charles D Burger, Genecelle B Delossantos, et al.
Page
of 29
Search research articles
Search
Showing results (221-230 of 285) with videos related to
Sort By:
Page
of 29
Pulmonary Pharmacology & Therapeutics
|
December 1, 2020
An expert panel delphi consensus statement on patient selection and management for transitioning between oral and inhaled treprostinil
Franck F Rahaghi, Roblee P Allen, Vijay P Balasubramanian, et al.
BMC Infectious Diseases
|
December 26, 2001
Absence of rapid selection for acyclovir or penciclovir resistance following suboptimal oral prodrug therapy of HSV-infected mice
R T Sarisky, H R Bartus, S A Dennis, et al.
Respiratory Medicine
|
March 19, 2023
Establishing a balloon pulmonary angioplasty program for chronic thromboembolic pulmonary hypertension: A United States single-center experience
Lauren N Carlozzi, Josh Lee, Lia M Barros, et al.
Annals of the American Thoracic Society
|
September 8, 2023
Regional Variation in Pulmonary Arterial Hypertension in the United States: The Pulmonary Hypertension Association Registry
Connor Fling, Teresa De Marco, Noah A Kime, et al.
Circulation. Heart Failure
|
October 22, 2024
Proteomic Signatures of Right Ventricular Outcomes in Pulmonary Arterial Hypertension
Hongyang Pi, Lu Xia, Olivier Boucherat, et al.
Antimicrobial Agents and Chemotherapy
|
May 11, 1992
Human immunodeficiency virus type 1 protease inhibitors irreversibly block infectivity of purified virions from chronically infected cells
D M Lambert, S R Petteway, C E McDanal, et al.
The American Journal of Cardiology
|
September 22, 2012
Von Willebrand factor and the right ventricle (the MESA-Right Ventricle Study)
Peter J Leary, R Graham Barr, David A Bluemke, et al.
Chest
|
January 6, 2025
Effect of Famotidine on Outcomes in Pulmonary Arterial Hypertension: A Randomized Controlled Trial
Peter J Leary, Samuel G Rayner, Kelley R H Branch, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
November 17, 2001
Biochemical characterization of a virus isolate, recovered from a patient with herpes keratitis, that was clinically resistant to acyclovir
R T Sarisky, R Cano, T T Nguyen, et al.
Annals of the American Thoracic Society
|
July 30, 2020
A Survey-based Estimate of COVID-19 Incidence and Outcomes among Patients with Pulmonary Arterial Hypertension or Chronic Thromboembolic Pulmonary Hypertension and Impact on the Process of Care
Joshua D Lee, Charles D Burger, Genecelle B Delossantos, et al.
Page
of 29